Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For LCID
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
17%
Per Share Metrics Best
100%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -1.16 4.66 4.72
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 67.93 -0.46 -1.43
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -2.79 2.06 2.12
Cash 3.01 1.74 1.68
Capex 27.62 -0.09 -0.12
Free Cash Flow 4.72 -0.31 -0.33
Revenue 9.45 0.08 0.07
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 16.51 -1.34 -1.61
Operating Margin 9.88 -4.23 -4.69
ROA 0.35 -0.08 -0.08
ROE -6.67 -0.14 -0.13
ROIC -0.71 -0.11 -0.11
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of LCID is permitted for members.
5 Growth
The "Growth Entry" for the Focus of LCID is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of LCID is permitted for members.